AI Insight
This qualitative study interviewed 20 healthcare professionals about diagnostic delays in rare cancers, revealing three key challenges: managing vague symptoms through clinical intuition and safety-netting strategies, navigating systemic delays despite accelerated care once cancer is suspected, and addressing patient distress caused by diagnostic uncertainty rather than the diagnosis itself. Healthcare professionals attempt to balance thorough investigation with timely diagnosis while managing patient anxiety throughout the process. The study highlights that diagnostic uncertainty creates significant psychological burden for patients even before a final diagnosis is reached.
Why it matters
The findings suggest that early psychosocial support during the diagnostic phase could reduce patient distress, particularly when dealing with vague symptoms and prolonged uncertainty. Understanding healthcare professionals' perspectives on diagnostic delays can inform system-level improvements and better support strategies for rare cancer patients navigating complex diagnostic pathways.
Understand the Science
Purpose:Delayed diagnosis in rare cancers can lead to disease progression, limited treatment options, and psychological distress, resulting in poorer quality of life and disability. We explored healthcare professionals’ (HCPs) perceptions of diagnostic delay in rare cancers and options for patient support.Materials and methodsSemi-structured interviews were conducted with 20 HCPs involved in rare cancer care. Interview topics covered diagnostic challenges, causes of delays, consequences for patients, and support options. Data were analyzed thematically.ResultsThree main themes emerged: (1) Time, intuition, and a safety-net fill the gap when signs are present, but not obvious. HCPs balance clinical intuition with safety-netting to avoid mis-, under-, or overdiagnosis when symptoms are vague, (2) Balancing speed and care in a fast-paced, complex diagnostic phase. Once cancer is suspected, the trajectory accelerates, yet systemic delays persist, and (3) Striving for precision: the paradox of reaching a diagnosis. While HCPs pursue diagnostic clarity, uncertainty often causes patients more distress than the diagnosis.ConclusionHCPs manage the diagnostic trajectory of rare cancers through clinical judgment, safety-netting, and clear communication. As systemic delays and patient distress remain, early psychosocial support may help. Future research should define diagnostic delay, assess its impact, and identify support options.